Trial Search Results

Heartsbreath Test for Heart Transplant Rejection

The purpose of this study is to demonstrate and validate a breath test for detection of biomarkers of heart transplant rejection (Grade 2R heart transplant).

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Menssana Research, Inc.

Collaborator: National Heart, Lung, and Blood Institute (NHLBI)

Stanford Investigator(s):


  • Device: BreathScanner 1.0
  • Device: BreathLink


Inclusion Criteria:

   - Subject is willing and able to cooperate with study, understand the scope of the
   study, and gives signed informed consent to participate.

   - Subject is the recipient of a heart transplant within the previous 12 months

   - Subject is scheduled for a routine endomyocardial biopsy

   - Subject is 18 years or older

Exclusion Criteria:

   - Evidence of acute intercurrent disease other than rejection reaction

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Hannah A Valantine, MD, MRCP, FACC